Martha L. Arango-Rodríguez

Foscal Hospital — Colombia

Medicine · Health Sciences

18h-index866citations33works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mesenchymal stem cell research(18), Diabetic Foot Ulcer Assessment and Management(7), RNA Interference and Gene Delivery(6), Wound Healing and Treatments(6), Tissue Engineering and Regenerative Medicine(6)

Publications33 total

Corrigendum to “Effect of biomolecules derived from human platelet-rich plasma on the ex vivo expansion of human adipose-derived mesenchymal stem cells for clinical applications” [Biologicals 75 (2022) 37–48]
Biologicals·2025
Efficacy of a single dose of cryopreserved human umbilical cord mesenchymal stromal cells for the treatment of knee osteoarthritis:a randomized, controlled, double-blind pilot study
Cytotherapy·2024· 10 cited
Treatment of osteonecrosis of the femoral head with multiple drilling and bone marrow mesenchymal stem cells expanded ex vivo plus biomolecules derived from platelet-rich plasma: a case report
PubMed Central·2023· 1 citedOpen Access
A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells
Stem Cell Research & Therapy·2023· 23 citedOpen Access
Técnica de Cierre de Agujero Macular Grande sin Pelado de Membrana Limitante Interna con Membrana de Plasma Rico en Factores de Crecimiento
Highlights of Vitreoretina·2023
A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells
2022Open Access
Mesenchymal stem cells for critical limb ischemia: their function, mechanism, and therapeutic potential
Stem Cell Research & Therapy·2022· 44 citedOpen Access
Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial
Cytotherapy·2022· 22 cited
Decellularized Tissues for Wound Healing: Towards Closing the Gap Between Scaffold Design and Effective Extracellular Matrix Remodeling
Frontiers in Bioengineering and Biotechnology·2022· 127 citedOpen Access
Effect of biomolecules derived from human platelet-rich plasma on the ex vivo expansion of human adipose-derived mesenchymal stem cells for clinical applications
Biologicals·2021· 3 cited
Security and efficacy of intradermal injection of mesenchymal stem cells derivatives on chronic diabetic foot ulcers: a randomized controlled clinical trial
Cytotherapy·2021
Impact of metalloproteinase motifs on the mechanical properties of pegda hydrogels as potential biodegradable scaffolds for wound healing
Cytotherapy·2021
Angiogenic and regenerative potential of mesenchymal stem cells in critical limb ischemia: A review of in vitro and in vivo evidence
Cytotherapy·2021
Mesenchymal stem cells derivatives as a novel and potential therapeutic approach to treat diabetic foot ulcers
Endocrinology Diabetes and Metabolism Case Reports·2020· 16 citedOpen Access
Pre-clinical Model of Bullous Keratopathy in Rabbit for Corneal Transplantation of Engineered Corneal Endothelial Grafts.
Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte)·2018Open Access
The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice
PLoS ONE·2017· 88 citedOpen Access
A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model
PLoS ONE·2017· 15 citedOpen Access
The administration of multipotent stromal cells at precancerous stage precludes tumor growth and epithelial dedifferentiation of oral squamous cell carcinoma
Stem Cell Research·2016· 27 citedOpen Access
Regenerative Potential of Mesenchymal Stromal Cells: Age‐Related Changes
Stem Cells International·2016· 86 citedOpen Access
Featured Article: Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells
Experimental Biology and Medicine·2015· 57 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Claudia Sossa(15), Víctor Alfonso Solarte-David(12), Silvia Becerra‐Bayona(10), Daniel Martínez‐Fong(8), Paulette Conget(7), Patricia Forgez(5), Ligia C Mateus(5), Lady T Giratá Viviescas(4), Fernando Ezquer(3), Carlos E. Orozco-Barrios(3), Rosa Angélica Castillo‐Rodríguez(3), Miguel Ochoa(3), Virgilio Galvis(2), Flavia Bruna(2), David Contador(2), Michael J. Bannon(2), Juan Antonio González-Barrios(2), Iván Navarro-Quiroga(2), Andrea K. Ardila-Roa(2), María Luna-González(2)